NovaBridge Biosciences
NBP
$3.21
-$0.03-0.93%
NASDAQ
| 09/30/2025 | 06/30/2025 | 12/31/2024 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 228.27M | 165.61M | 173.40M | 173.40M | -- |
| Total Receivables | 926.00K | 784.00K | 1.17M | 1.17M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.47M | 1.24M | 1.13M | 1.13M | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.10M | -- | 998.00K | 998.00K | -- |
| Total Current Assets | 232.78M | 167.64M | 176.69M | 176.69M | -- |
|
|
|||||
| Total Current Assets | 232.78M | 167.64M | 176.69M | 176.69M | -- |
| Net Property, Plant & Equipment | 3.17M | 3.38M | 3.80M | 3.80M | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.15M | 1.22M | 1.37M | 1.37M | -- |
| Total Assets | 277.41M | 206.71M | 212.68M | 212.68M | -- |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 8.03M | 6.49M | 7.53M | 7.53M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 872.00K | 853.00K | 816.00K | 816.00K | -- |
| Total Finance Division Other Current Liabilities | 7.19M | -- | 106.00K | 106.00K | -- |
| Total Other Current Liabilities | 7.19M | -- | 106.00K | 106.00K | -- |
| Total Current Liabilities | 16.09M | 7.35M | 8.45M | 8.45M | -- |
|
|
|||||
| Total Current Liabilities | 16.09M | 7.35M | 8.45M | 8.45M | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.40M | 2.63M | 3.07M | 3.07M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 18.50M | 9.98M | 11.52M | 11.52M | -- |
|
|
|||||
| Common Stock & APIC | 1.52B | 1.46B | 1.46B | 1.46B | -- |
| Retained Earnings | -1.30B | -1.29B | -1.29B | -1.29B | -- |
| Treasury Stock & Other | 37.65M | 31.43M | 27.16M | 27.16M | -- |
| Total Common Equity | 258.92M | 196.73M | 201.16M | 201.16M | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 258.92M | 196.73M | 201.16M | 201.16M | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 258.92M | 196.73M | 201.16M | 201.16M | -- |
|
|
|||||